Univariable analysis revealed that among age, ECOG score, HRD status, BRCA status, and mutation in HRR genes, only HRD status showed a statistically marginally significant association with a PFS benefit in the platinum-containing group ( Supplementary Table S7 ).
← all excerpts
Association between homologous recombination deficiency and outcomes with platinum and platinum-free chemotherapy in patients with triple-negative breast cancer.
1
—
—